Mouse embryonic stem cells undergo charontosis, a novel programmed cell death pathway dependent upon cathepsins, p53, and EndoG, in response to etoposide treatment

Stem Cell Research

Volumn 10, Issue 3, 2013, Pages 428-441

  Tichy, Elisia D ^a   Stephan, Zachary A ^a   Osterburg, Andrew ^b   Noel, Greg ^b   Stambrook, Peter J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN H; CATHEPSIN L; CATHEPSIN S; ENDOG PROTEIN; ETOPOSIDE; PIFITHRIN ALPHA; PIFITHRIN MU; PROTECTIVE AGENT; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELLULAR PARAMETERS; CHARONTOSIS; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG RESPONSE; EMBRYONIC STEM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASES; CATHEPSINS; CELL LINE; EMBRYONIC STEM CELLS; ENDODEOXYRIBONUCLEASES; ETOPOSIDE; MICE; MICE, INBRED C57BL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84875278391     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.01.010     Document Type: Article

References (100)

1. Aladjem M.I., Spike B.T., Rodewald L.W., Hope T.J., Klemm M., Jaenisch R., Wahl G.M. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol. 1998, 8:145-155.
2. Alonso R., Lopez-Guerra M., Upshaw R., Bantia S., Smal C., Bontemps F., Manz C., Mehrling T., Villamor N., Campo E., Montserrat E., Colomer D. Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM. Blood 2009, 114:1563-1575.
3. Amaravadi R.K., Yu D., Lum J.J., Bui T., Christophorou M.A., Evan G.I., Thomas-Tikhonenko A., Thompson C.B. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 2007, 117:326-336.
4. Amaravadi R.K., Lippincott-Schwartz J., Yin X.M., Weiss W.A., Takebe N., Timmer W., DiPaola R.S., Lotze M.T., White E. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 2011, 17:654-666.
5. Apel A., Herr I., Schwarz H., Rodemann H.P., Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res. 2008, 68:1485-1494.
6. Arriola E.L., Lopez A.R., Chresta C.M. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop. Oncogene 1999, 18:1081-1091.
7. Ashcroft M., Taya Y., Vousden K.H. Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol. 2000, 20:3224-3233.
8. Baldwin E.L., Osheroff N. Etoposide, topoisomerase II and cancer. Curr. Med. Chem. Anticancer Agents 2005, 5:363-372.
9. Bialik S., Kimchi A. DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death. Semin. Cancer Biol. 2004, 14:283-294.
10. Bragado P., Armesilla A., Silva A., Porras A. Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis 2007, 12:1733-1742.
11. Broker L.E., Huisman C., Span S.W., Rodriguez J.A., Kruyt F.A., Giaccone G. Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res. 2004, 64:27-30.
12. Cervantes R.B., Stringer J.R., Shao C., Tischfield J.A., Stambrook P.J. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3586-3590.
13. Chaitanya G.V., Steven A.J., Babu P.P. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal. 2010, 8:31.
14. Chang J.W., Choi H., Cotman S.L., Jung Y.K. Lithium rescues the impaired autophagy process in CbCln3(δex7/8/δex7/8) cerebellar cells and reduces neuronal vulnerability to cell death via IMPase inhibition. J. Neurochem. 2011, 116:659-668.
15. Chen S.Y., Chiu L.Y., Maa M.C., Wang J.S., Chien C.L., Lin W.W. zVAD-induced autophagic cell death requires c-Src-dependent ERK and JNK activation and reactive oxygen species generation. Autophagy 2011, 7:217-228.
16. Christofferson D.E., Yuan J. Necroptosis as an alternative form of programmed cell death. Curr. Opin. Cell Biol. 2010, 22:263-268.
17. Clifford B., Beljin M., Stark G.R., Taylor W.R. G2 arrest in response to topoisomerase II inhibitors: the role of p53. Cancer Res. 2003, 63:4074-4081.
18. Codelia V.A., Cisterna M., Alvarez A.R., Moreno R.D. p73 participates in male germ cells apoptosis induced by etoposide. Mol. Hum. Reprod. 2010, 16:734-742.
19. Cote J., Ruiz-Carrillo A. Primers for mitochondrial DNA replication generated by endonuclease G. Science 1993, 261:765-769.
20. Declercq W., Vanden Berghe T., Vandenabeele P. RIP kinases at the crossroads of cell death and survival. Cell 2009, 138:229-232.
21. Dohn M., Zhang S., Chen X. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 2001, 20:3193-3205.
22. Droga-Mazovec G., Bojic L., Petelin A., Ivanova S., Romih R., Repnik U., Salvesen G.S., Stoka V., Turk V., Turk B. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J. Biol. Chem. 2008, 283:19140-19150.
23. Edinger A.L., Thompson C.B. Death by design: apoptosis, necrosis and autophagy. Curr. Opin. Cell Biol. 2004, 16:663-669.
24. Emert-Sedlak L., Shangary S., Rabinovitz A., Miranda M.B., Delach S.M., Johnson D.E. Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death. Mol. Cancer Ther. 2005, 4:733-742.
25. England K., O'Driscoll C., Cotter T.G. Carbonylation of glycolytic proteins is a key response to drug-induced oxidative stress and apoptosis. Cell Death Differ. 2004, 11:252-260.
26. Feoktistova M., Geserick P., Kellert B., Dimitrova D.P., Langlais C., Hupe M., Cain K., MacFarlane M., Hacker G., Leverkus M. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 2011, 43:449-463.
27. Fernando P., Brunette S., Megeney L.A. Neural stem cell differentiation is dependent upon endogenous caspase 3 activity. FASEB J. 2005, 19:1671-1673.
28. Findeisen M., Vennemann M., Brinkmann B., Ortmann C., Rose I., Kopcke W., Jorch G., Bajanowski T. German study on sudden infant death (GeSID): design, epidemiological and pathological profile. Int. J. Legal Med. 2004, 118:163-169.
29. Fischer U., Janicke R.U., Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 2003, 10:76-100.
30. Flores E.R., Tsai K.Y., Crowley D., Sengupta S., Yang A., McKeon F., Jacks T. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002, 416:560-564.
31. Fujino M., Li X.K., Kitazawa Y., Guo L., Kawasaki M., Funeshima N., Amano T., Suzuki S. Distinct pathways of apoptosis triggered by FTY720, etoposide, and anti-Fas antibody in human T-lymphoma cell line (Jurkat cells). J. Pharmacol. Exp. Ther. 2002, 300:939-945.
32. Fujita J., Crane A.M., Souza M.K., Dejosez M., Kyba M., Flavell R.A., Thomson J.A., Zwaka T.P. Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2008, 2:595-601.
33. Galluzzi L., Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell 2008, 135:1161-1163.
34. Galluzzi L., Vanden Berghe T., Vanlangenakker N., Buettner S., Eisenberg T., Vandenabeele P., Madeo F., Kroemer G. Programmed necrosis from molecules to health and disease. Int. Rev. Cell Mol. Biol. 2011, 289:1-35.
35. Gobeil S., Boucher C.C., Nadeau D., Poirier G.G. Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ. 2001, 8:588-594.
36. Goehe, R. W., Di, X., Sharma, K., Bristol, M., Henderson, S., Valerie, K., Rodier, F., Davalos, A., Gewirtz, D., 2012. The autophagy-senescence connection in chemotherapy; must tumor cells (self) eat before they sleep? J Pharmacol Exp Ther.
37. Grandela C., Pera M.F., Grimmond S.M., Kolle G., Wolvetang E.J. p53 is required for etoposide-induced apoptosis of human embryonic stem cells. Stem Cell Res. 2007, 1:116-128.
38. Guo Y., Mantel C., Hromas R.A., Broxmeyer H.E. Oct-4 is critical for survival/antiapoptosis of murine embryonic stem cells subjected to stress: effects associated with Stat3/survivin. Stem Cells 2008, 26:30-34.
39. Guo X.L., Li D., Hu F., Song J.R., Zhang S.S., Deng W.J., Sun K., Zhao Q.D., Xie X.Q., Song Y.J., Wu M.C., Wei L.X. Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Lett. 2012, 320:171-179.
40. Han W., Sun J., Feng L., Wang K., Li D., Pan Q., Chen Y., Jin W., Wang X., Pan H., Jin H. Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells. PLoS One 2011, 6:e28491.
41. Higgins G.C., Beart P.M., Nagley P. Oxidative stress triggers neuronal caspase-independent death: endonuclease G involvement in programmed cell death-type III. Cell. Mol. Life Sci. 2009, 66:2773-2787.
42. Hirano T., Kawai K., Ootsuyama Y., Orimo H., Kasai H. Detection of a mouse OGG1 fragment during caspase-dependent apoptosis: oxidative DNA damage and apoptosis. Cancer Sci. 2004, 95:634-638.
43. Hsu K.F., Wu C.L., Huang S.C., Wu C.M., Hsiao J.R., Yo Y.T., Chen Y.H., Shiau A.L., Chou C.Y. Cathepsin L mediates resveratrol-induced autophagy and apoptotic cell death in cervical cancer cells. Autophagy 2009, 5:451-460.
44. Hughson L.R., Poon V.I., Spowart J.E., Lum J.J. Implications of therapy-induced selective autophagy on tumor metabolism and survival. Int. J. Cell Biol. 2012, 2012:872091.
45. Ishihara Y., Shimamoto N. Involvement of endonuclease G in nucleosomal DNA fragmentation under sustained endogenous oxidative stress. J. Biol. Chem. 2006, 281:6726-6733.
46. Jiang M., Wei Q., Wang J., Du Q., Yu J., Zhang L., Dong Z. Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis. Oncogene 2006, 25:4056-4066.
47. Johansson A.C., Appelqvist H., Nilsson C., Kagedal K., Roberg K., Ollinger K. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis 2010, 15:527-540.
48. Johnson D.E. Noncaspase proteases in apoptosis. Leukemia 2000, 14:1695-1703.
49. Joza N., Susin S.A., Daugas E., Stanford W.L., Cho S.K., Li C.Y., Sasaki T., Elia A.J., Cheng H.Y., Ravagnan L., Ferri K.F., Zamzami N., Wakeham A., Hakem R., Yoshida H., Kong Y.Y., Mak T.W., Zuniga-Pflucker J.C., Kroemer G., Penninger J.M. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001, 410:549-554.
50. Kagedal K., Johansson U., Ollinger K. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J. 2001, 15:1592-1594.
51. Karpinich N.O., Tafani M., Rothman R.J., Russo M.A., Farber J.L. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J. Biol. Chem. 2002, 277:16547-16552.
52. Kawahara A., Ohsawa Y., Matsumura H., Uchiyama Y., Nagata S. Caspase-independent cell killing by Fas-associated protein with death domain. J. Cell Biol. 1998, 143:1353-1360.
53. Klein J.A., Longo-Guess C.M., Rossmann M.P., Seburn K.L., Hurd R.E., Frankel W.N., Bronson R.T., Ackerman S.L. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 2002, 419:367-374.
54. Kroemer G., Levine B. Autophagic cell death: the story of a misnomer. Nat. Rev. Mol. Cell Biol. 2008, 9:1004-1010.
55. Larsen B.D., Rampalli S., Burns L.E., Brunette S., Dilworth F.J., Megeney L.A. Caspase 3/caspase-activated DNase promote cell differentiation by inducing DNA strand breaks. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:4230-4235.
56. Lee S.B., Tong S.Y., Kim J.J., Um S.J., Park J.S. Caspase-independent autophagic cytotoxicity in etoposide-treated CaSki cervical carcinoma cells. DNA Cell Biol. 2007, 26:713-720.
57. Levine B., Yuan J. Autophagy in cell death: an innocent convict?. J. Clin. Invest. 2005, 115:2679-2688.
58. Li L.Y., Luo X., Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001, 412:95-99.
59. Li N., Zheng Y., Chen W., Wang C., Liu X., He W., Xu H., Cao X. Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis. Cancer Res. 2007, 67:11176-11185.
60. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997, 89:175-184.
61. Liu J., Xia H., Kim M., Xu L., Li Y., Zhang L., Cai Y., Norberg H.V., Zhang T., Furuya T., Jin M., Zhu Z., Wang H., Yu J., Hao Y., Choi A., Ke H., Ma D., Yuan J. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 2011, 147:223-234.
62. Mantel C., Guo Y., Lee M.R., Kim M.K., Han M.K., Shibayama H., Fukuda S., Yoder M.C., Pelus L.M., Kim K.S., Broxmeyer H.E. Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability. Blood 2007, 109:4518-4527.
63. Marchenko N.D., Zaika A., Moll U.M. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem. 2000, 275:16202-16212.
64. Mayorga M., Bahi N., Ballester M., Comella J.X., Sanchis D. Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death. J. Biol. Chem. 2004, 279:34882-34889.
65. Melino G., Bernassola F., Ranalli M., Yee K., Zong W.X., Corazzari M., Knight R.A., Green D.R., Thompson C., Vousden K.H. p73 induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J. Biol. Chem. 2004, 279:8076-8083.
66. Menendez D., Shatz M., Azzam K., Garantziotis S., Fessler M.B., Resnick M.A. The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet. 2011, 7:e1001360.
67. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 2003, 11:577-590.
68. Mizumoto K., Rothman R.J., Farber J.L. Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide. Mol. Pharmacol. 1994, 46:890-895.
69. Munoz-Gamez J.A., Rodriguez-Vargas J.M., Quiles-Perez R., Aguilar-Quesada R., Martin-Oliva D., de Murcia G., Menissier de Murcia J., Almendros A., Ruiz de Almodovar M., Oliver F.J. PARP-1 is involved in autophagy induced by DNA damage. Autophagy 2009, 5:61-74.
70. Musch T., Oz Y., Lyko F., Breiling A. Nucleoside drugs induce cellular differentiation by caspase-dependent degradation of stem cell factors. PLoS One 2010, 5:e10726.
71. Nakagawa K., Taya Y., Tamai K., Yamaizumi M. Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks. Mol. Cell. Biol. 1999, 19:2828-2834.
72. Nam C., Doi K., Nakayama H. Etoposide induces G2/M arrest and apoptosis in neural progenitor cells via DNA damage and an ATM/p53-related pathway. Histol. Histopathol. 2010, 25:485-493.
73. Orlotti N.I., Cimino-Reale G., Borghini E., Pennati M., Sissi C., Perrone F., Palumbo M., Daidone M.G., Folini M., Zaffaroni N. Autophagy acts as a safeguard mechanism against G-quadruplex ligand-mediated DNA damage. Autophagy 2012, 8.
74. Petre-Lazar B., Livera G., Moreno S.G., Trautmann E., Duquenne C., Hanoux V., Habert R., Coffigny H. The role of p63 in germ cell apoptosis in the developing testis. J. Cell. Physiol. 2007, 210:87-98.
75. Pettersen A.A., Seljeflot I., Abdelnoor M., Arnesen H. Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design. Scand. Cardiovasc. J. 2004, 38:353-356.
76. Pyati U.J., Gjini E., Carbonneau S., Lee J.S., Guo F., Jette C.A., Kelsell D.P., Look A.T. p63 mediates an apoptotic response to pharmacological and disease-related ER stress in the developing epidermis. Dev. Cell 2011, 21:492-505.
77. Rana S., Gupta K., Gomez J., Matsuyama S., Chakrabarti A., Agarwal M.L., Agarwal A., Agarwal M.K., Wald D.N. Securinine induces p73-dependent apoptosis preferentially in p53-deficient colon cancer cells. FASEB J. 2010, 24:2126-2134.
78. Reece K.M., Figg W.D. A novel regulator (USP10) of p53: implications for tumor suppression and therapeutic targeting. Cancer Biol. Ther. 2010, 9:583-584.
79. Rojas E., Mussali P., Tovar E., Valverde M. DNA-AP sites generation by etoposide in whole blood cells. BMC Cancer 2009, 9:398.
80. Samejima K., Earnshaw W.C. ICAD/DFF regulator of apoptotic nuclease is nuclear. Exp. Cell Res. 1998, 243:453-459.
81. Schneider-Stock R., Diab-Assef M., Rohrbeck A., Foltzer-Jourdainne C., Boltze C., Hartig R., Schonfeld P., Roessner A., Gali-Muhtasib H. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms. J. Pharmacol. Exp. Ther. 2005, 312:525-536.
82. Shimizu S., Kanaseki T., Mizushima N., Mizuta T., Arakawa-Kobayashi S., Thompson C.B., Tsujimoto Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 2004, 6:1221-1228.
83. Shingu T., Fujiwara K., Bogler O., Akiyama Y., Moritake K., Shinojima N., Tamada Y., Yokoyama T., Kondo S. Stage-specific effect of inhibition of autophagy on chemotherapy-induced cytotoxicity. Autophagy 2009, 5:537-539.
84. Sleiman R.J., Stewart B.W. Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death. Clin. Cancer Res. 2000, 6:3756-3765.
85. Smith P.J., Soues S., Gottlieb T., Falk S.J., Watson J.V., Osborne R.J., Bleehen N.M. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells. Br. J. Cancer 1994, 70:914-921.
86. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397:441-446.
87. Tenev T., Bianchi K., Darding M., Broemer M., Langlais C., Wallberg F., Zachariou A., Lopez J., MacFarlane M., Cain K., Meier P. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol. Cell 2011, 43:432-448.
88. Tichy E.D. Mechanisms maintaining genomic integrity in embryonic stem cells and induced pluripotent stem cells. Exp. Biol. Med. (Maywood) 2011, 236:987-996.
89. Tichy E.D., Pillai R., Deng L., Liang L., Tischfield J., Schwemberger S.J., Babcock G.F., Stambrook P.J. Mouse embryonic stem cells, but not somatic cells, predominantly use homologous recombination to repair double-strand DNA breaks. Stem Cells Dev. 2010, 19:1699-1711.
90. Tichy E.D., Liang L., Deng L., Tischfield J., Schwemberger S., Babcock G., Stambrook P.J. Mismatch and base excision repair proficiency in murine embryonic stem cells. DNA Repair (Amst) 2011, 10:445-451.
91. Tsujimoto Y. Apoptosis and necrosis: intracellular ATP level as a determinant for cell death modes. Cell Death Differ. 1997, 4:429-434.
92. Tu H.C., Ren D., Wang G.X., Chen D.Y., Westergard T.D., Kim H., Sasagawa S., Hsieh J.J., Cheng E.H. The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:1093-1098.
93. Van Sloun P.P., Jansen J.G., Weeda G., Mullenders L.H., van Zeeland A.A., Lohman P.H., Vrieling H. The role of nucleotide excision repair in protecting embryonic stem cells from genotoxic effects of UV-induced DNA damage. Nucleic Acids Res. 1999, 27:3276-3282.
94. Walton M.I., Wilson S.C., Hardcastle I.R., Mirza A.R., Workman P. An evaluation of the ability of pifithrin-alpha and -beta to inhibit p53 function in two wild-type p53 human tumor cell lines. Mol. Cancer Ther. 2005, 4:1369-1377.
95. Xie B.S., Zhao H.C., Yao S.K., Zhuo D.X., Jin B., Lv D.C., Wu C.L., Ma D.L., Gao C., Shu X.M., Ai Z.L. Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2 cells. Int. J. Mol. Med. 2011, 27:599-606.
96. Yamamoto A., Tagawa Y., Yoshimori T., Moriyama Y., Masaki R., Tashiro Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 1998, 23:33-42.
97. Yoo S.H., Yoon Y.G., Lee J.S., Song Y.S., Oh J.S., Park B.S., Kwon T.K., Park C., Choi Y.H., Yoo Y.H. Etoposide induces a mixed type of programmed cell death and overcomes the resistance conferred by Bcl-2 in Hep3B hepatoma cells. Int. J. Oncol. 2012, 41:1443-1454.
98. Yu L., Alva A., Su H., Dutt P., Freundt E., Welsh S., Baehrecke E.H., Lenardo M.J. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304:1500-1502.
99. Yuan X.M., Li W., Dalen H., Lotem J., Kama R., Sachs L., Brunk U.T. Lysosomal destabilization in p53-induced apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6286-6291.
100. Zuzarte-Luis V., Montero J.A., Kawakami Y., Izpisua-Belmonte J.C., Hurle J.M. Lysosomal cathepsins in embryonic programmed cell death. Dev. Biol. 2007, 301:205-217.